resources

Support for the Ensuring Pathways to Innovative Cures (EPIC) Act
9/13/24 Sign-on Letter to Congress   Infographic: EPIC Act Needed to Protect Access to Medications for People Living with Chronic Conditions    Webinar: Preserving Incentives for Development...
FEWER TREATMENTS RESULTING FROM IRA PRICE CONTROLS
November 12, 2024 (Virtual) Lumanity's IRA Webinar Series - Part 2: IRA Impact on Innovation in Drug Development - RSVP HERE   Case studies highlight peril to treatment advances across several disease states...
PRESCRIPTION DRUG AFFORDABILITY BOARDS WILL LIMIT ACCESS TO LIFESAVING MEDICINES
  Press Statement - New Insurer Perspectives Highlight Considerable Patient Challenges Anticipated from Prescription Drug Affordability Boards White Paper - Health Plans Predict:...
Defining "Unmet Medical Need"
Patients, people with disabilities, and their caregivers want their experiences and outcomes that matter to them to be considered when the government or other payers make decisions about their treatments. The Inflation...
NCD with CED is not the path forward for patients and families managing Alzheimer's Disease or other related dementias
INFOGRAPHIC - Leaving Medicare Beneficiaries in Limbo   INFOGRAPHIC - The Long Road to Treatment: Medicare's CED Clinical Trial Policy    INFOGRAPHIC - Patient Registries...
U.S. Burden of Neurodegenerative Disease
Neurodegenerative disease arises when nerve cells in the brain or other parts of the nervous system lose function and eventually die. Currently available treatments may relieve some of the associated symptoms, but there...
National Pandemic Preparedness Strategy Statement of Principles
To anticipate and prepare for future pandemics, the United States needs to develop an effective National Pandemic Preparedness Strategy (NPPS) focused not only on the infectious pathogen, but also resulting,...
Quantifying Impact of Accelerated Approval Drugs on Medicaid Spending: De Minimus Impact, Maximum Attention
States seek to limit coverage of drugs approved through the FDA’s accelerated approval pathway designed to accelerate availability of medications that treat serious or life-threatening conditions...